- Home
- PLRZ vs AMIX Comparison
PLRZ vs AMIX Comparison
Compare PLRZ & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRZ
- AMIX
- Stock Information
- Founded
- PLRZ 2005
- AMIX 2014
- Country
- PLRZ Israel
- AMIX United States
- Employees
- PLRZ N/A
- AMIX N/A
- Industry
- PLRZ
- AMIX
- Sector
- PLRZ
- AMIX
- Exchange
- PLRZ NYSE
- AMIX NYSE
- Market Cap
- PLRZ 3.7M
- AMIX 3.5M
- IPO Year
- PLRZ 2024
- AMIX N/A
- Fundamental
- Price
- PLRZ $0.71
- AMIX $1.43
- Analyst Decision
- PLRZ
- AMIX Strong Buy
- Analyst Count
- PLRZ 0
- AMIX 1
- Target Price
- PLRZ N/A
- AMIX $5.00
- AVG Volume (30 Days)
- PLRZ 2.9M
- AMIX 2.4M
- Earning Date
- PLRZ 02-15-2025
- AMIX 08-12-2025
- Dividend Yield
- PLRZ N/A
- AMIX N/A
- EPS Growth
- PLRZ N/A
- AMIX N/A
- EPS
- PLRZ N/A
- AMIX N/A
- Revenue
- PLRZ N/A
- AMIX N/A
- Revenue This Year
- PLRZ N/A
- AMIX N/A
- Revenue Next Year
- PLRZ N/A
- AMIX N/A
- P/E Ratio
- PLRZ N/A
- AMIX N/A
- Revenue Growth
- PLRZ N/A
- AMIX N/A
- 52 Week Low
- PLRZ $0.55
- AMIX $1.14
- 52 Week High
- PLRZ $1,200.00
- AMIX $42.40
- Technical
- Relative Strength Index (RSI)
- PLRZ N/A
- AMIX 47.75
- Support Level
- PLRZ N/A
- AMIX $1.32
- Resistance Level
- PLRZ N/A
- AMIX $1.60
- Average True Range (ATR)
- PLRZ 0.00
- AMIX 0.20
- MACD
- PLRZ 0.00
- AMIX 0.02
- Stochastic Oscillator
- PLRZ 0.00
- AMIX 16.67
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.